Azurity Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals, Inc.
| Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited |
| Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2023cv01080 |
| September 29, 2023 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 22, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 ANSWER and Affirmative Defenses to #1 Complaint, COUNTERCLAIM against Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited by Teva Pharmaceuticals, Inc..(Keller, Karen) Modified on 11/27/2023 (mdb). |
Filing 13
SO ORDERED re #12 Stipulation Dismissing Teva Pharmaceutical Industries Ltd. Party Teva Pharmaceutical Industries Ltd. terminated. Signed by Judge Maryellen Noreika on 11/6/2023. (dlw)
|
| Filing 12 STIPULATION of Dismissal as to Teva Pharmaceutical Industries Ltd. by Teva Pharmaceuticals, Inc. (Keller, Karen) Modified on 11/6/2023 (dlw). |
|
SO ORDERED re (11 in 1:23-cv-01080-MN, 18 in 1:23-cv-00833-MN) MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 10/31/2023. (dlw)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: #1 Certifications for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno)(Joyce, Alexandra) |
| Filing 10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to November 22, 2023 - filed by Teva Pharmaceuticals, Inc.. (Keller, Karen) |
|
SO ORDERED re #10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to November 22, 2023 (Set/Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 11/22/2023). ORDERED by Judge Maryellen Noreika on 10/12/2023. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 9 SUMMONS Returned Executed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.Teva Pharmaceuticals, Inc. served on 10/2/2023, answer due 10/23/2023. (Joyce, Alexandra) |
| Filing 8 Summons Issued as to Teva Pharmaceuticals, Inc. on 9/29/2023. (twk) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Master Trust Bank of Japan, Ltd. for Takeda Pharmaceutical Company Limited filed by Takeda Pharmaceutical Company Limited. (twk) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc., Other Affiliate Azurity Pharmaceuticals, Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,936; 9,169,238; 9,387,249. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 17, 2023 (ANDA No. 218737). Date of Expiration of Patent: 9,066,936 (March 26, 2028); 9,169,238 (February 4, 2030); 9,387,249 (July 1, 2031). Thirty Month Stay Deadline: February 17, 2026 (ANDA No. 218737). (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, Inc. (Filing fee $402, receipt number ADEDC-4236549.) - filed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
